Tuberculosis of fallopian tube

Fallopian tube tuberculosis is a disease that many people have not heard of. It is mainly caused by bacterial inflammation. The principle of treatment is to first carry out early anti-tuberculosis treatment, which needs to be coordinated with drug treatment. According to the degree of recovery of the disease, choose the appropriate treatment plan. In addition, during the treatment process, pay attention to regular examinations and care when necessary, so that recovery will be faster.

The fallopian tube is the main affected organ in genital tuberculosis, accounting for 85% to 95%. Tuberculosis infection during prepubertal years rarely results in genital tract infection.

Medication

1. Anti-tuberculosis treatment Principles of anti-tuberculosis treatment: early, regular, full course, appropriate dosage, and combination use. There are two methods of anti-tuberculosis drug treatment: long-term standard treatment and short-term treatment.

Long-term standard treatment: triple therapy with streptomycin, isoniazid, and sodium aminosalicylate, with a course of 1.5 to 2 years. The lesions can be absorbed and are stable, reaching the cure standard of no recurrence. However, due to the long course of treatment, some patients are unwilling to persist in taking the medication because their symptoms disappear. Irregular treatment is often the cause of drug resistance, and ultimately the treatment is incomplete.

The treatment plan is to use streptomycin, isoniazid and sodium para-aminosalicylate every day for the first month, and then use isoniazid and sodium para-aminosalicylate for 10 months, or choose streptomycin, isoniazid and sodium para-aminosalicylate for 2 months, use streptomycin twice a week, isoniazid and sodium para-aminosalicylate every day for 3 months, and use isoniazid and sodium para-aminosalicylate for 7 months.

The basic mechanism of short-course therapy is that the treatment plan must have the effect of quickly killing various tuberculosis bacteria in the body, that is, killing the extracellular tuberculosis bacteria that reproduce rapidly and intermittently in a neutral environment within a relatively short course of treatment, while at the same time eliminating the intracellular tuberculosis bacteria that have low metabolism and reproduce slowly in an acidic environment. Based on this, the treatment plan must be combined with drugs that have bactericidal and sterilizing effects. Short-term treatment options include:

(1) Isoniazid 300 mg, orally, once a day, and rifampicin 10-20 mg/kg, maximum dose 600 mg, orally, once a day. The above two drugs are used for a course of 9 months.

(2) For patients with severe disease or tuberculous peritonitis, an enhanced regimen is used. Isoniazid 300 mg, orally, once a day. Rifampicin 600 mg, orally, once a day. Pyrazinamide is only effective against human tuberculosis, with an oral dose of 30 to 40 mg/(kg·d). The above three drugs are used together for 2 months, followed by isoniazid and rifampicin for 7 months, with the same dosage as above. The whole course of treatment lasts 9 months.

(3) For patients with drug resistance or severe disease, streptomycin can be added to the above three drugs, 0.75-1.0 g/d, i.e. 10-20 mg/kg, intramuscular injection, that is, four drugs are used together for a total of 2 months. Subsequently, depending on the condition and drug sensitivity test, 2 or 3 drugs were used and treatment was continued for 4 months.

(3) Ethambutol is the drug of choice and can be used with isoniazid and